Strategic Research Initiatives | Strategic Research Initiative Development Grants
Discovery Advancement Program (DAP) | Strategic Research Resources
Strategic Research Resources
The Pre-Clinical Resources program facilitates the translation
of Pre-Clinical science to clinical science for industry.
Whether you need to evaluate potential anti-arthritis drugs for clinical use or evaluate the mechanism of action for drug candidates, the Network's highly qualified experts can develop and implement specific protocols to meet your needs.
Our resources include:
In vitro diagnostics and screening systems
A number of proprietary and public domain screening systems are available to measure the impact of treatments on various biological markers of musculoskeletal diseases.
- Biomarkers
- Prognostic and Predictive Indicators
- Imaging
- In vitro screening
- Animal model (non-GLP and GLP), in both proprietary and traditional models
Osteoarthritis
Rabbit model of osteoarthritis
Tissue repair
Sheep model of articular repair
Analytical services
- Histopathology
- Gross morphology
- Immunohistochemistry
- In situ hybridization
- Histomorphology
- SEM and TEM
- Hematology
- Immunology
- Clinical biochemistry
- Molecular genetics
- Cytogenetics
- Biomarker assays
- Expert consultants
CAN provides access to experts in:
- protocol design
- method validation
- review and analysis of data
For more information, contact:
Johnathan Riley
Managing Director
Phone: 416-586-3167
E-mail: jriley@arthritisnetwork.ca
Return To Top | Strategic Research Resources
|
